Thompson Mayra J, Carr Bruce R
Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Int J Womens Health. 2016 May 17;8:145-9. doi: 10.2147/IJWH.S105955. eCollection 2016.
A debate among gynecologic and reproductive surgeons is whether or not there is a clinical need to treat all intramural myomas. Considerations include myoma size and number, ability to access them, whether or not they compromise the endometrium, and treatment effect on gynecologic, reproductive, and obstetric outcomes. We conducted a detailed study regarding intramural myomas, their prevalence in subject populations, the imaging methods used to detect them, their growth rate, their suspected adverse effects on gynecologic, fertility, and obstetric outcomes, and the effectiveness of various treatment methods. The growing body of evidence reported in the literature supports the need to manage intramural myomas and to treat them appropriately.
妇科和生殖外科医生之间的一个争论点是,临床上是否有必要治疗所有的壁间肌瘤。需要考虑的因素包括肌瘤的大小和数量、能否触及肌瘤、肌瘤是否累及子宫内膜,以及治疗对妇科、生殖和产科结局的影响。我们针对壁间肌瘤、其在研究对象群体中的患病率、用于检测它们的成像方法、它们的生长速度、它们对妇科、生育能力和产科结局的疑似不良影响,以及各种治疗方法的有效性进行了一项详细研究。文献中报道的越来越多的证据支持对壁间肌瘤进行管理并给予适当治疗的必要性。